Twist Bioscience

Forecast & Rating11 analysts currently cover Twist Bioscience, with about 81.8% giving a positive rating — meaning they expect the stock to rise. The average price target is $105.30, about 19.6% downside from the current price of $131.00. Price targets range from $36.00 to $120.00 — a wide spread, showing clear disagreement over just how much Twist Bioscience can rise. Historically, about 76.9% of past price targets were eventually met, which adds credibility. For you, this means most professionals who study Twist Bioscience closely still see room for the stock to rise. Data as of Aug 31, 2026; for reference only and not investment advice.